VirtualScopics, Inc. (NASDAQ: VSCP) provides superior precision and reproducibility through their computer-assisted analysis techniques. The company’s technologies enable faster and more reliable detection of disease progression or therapeutic benefit, accelerating the clinical trial process, and providing a foundation for future diagnostic applications. VirtualScopics’ originates from research initially undertaken at the University of Rochester Medical Center and School of Engineering. For further information, visit the Company’s web site at www.virtualscopics.com.
- 17 years ago
 
		QualityStocks		
			VirtualScopics, Inc. (NASDAQ: VSCP)
				Tags Rodman & Renshaw
		
			    	
				    Related Post
					
			- 
											                QualityStocksNewsBreaks – NextPlat Corp. (NASDAQ: NXPL, NXPLW) to Announce Q3 2025 Financial Results on Nov. 13
NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology…
 - 
											                QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FRA: GDT0) Launches Corporate and Premium Cybersecurity Plans
This article has been disseminated on behalf of Sekur Private Data and may include paid…
 - 
											                Soligenix Inc. (NASDAQ: SNGX) Strengthens Advisory Leadership in Cutaneous T-Cell Lymphoma
Soligenix revealed updates to its U.S. Medical Advisory Board for CTCL designed to support the…